BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Thursday. The firm set a “sell” rating on the medical technology company’s stock.

A number of other analysts have also commented on BIOL. Benchmark reiterated a “speculative buy” rating and set a $0.40 price target on shares of BIOLASE in a report on Wednesday. Ascendiant Capital Markets dropped their price target on BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd.

BIOLASE Price Performance

BIOL stock opened at $0.02 on Thursday. BIOLASE has a twelve month low of $0.02 and a twelve month high of $1.94. The stock’s 50 day moving average is $0.06 and its 200-day moving average is $0.11. The firm has a market capitalization of $517,808.50, a PE ratio of 0.00 and a beta of 0.67.

BIOLASE (NASDAQ:BIOL) last issued its quarterly earnings results on Thursday, August 8th. The medical technology company reported ($0.08) EPS for the quarter. The business had revenue of $11.56 million for the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 41.65%.

Institutional Trading of BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC raised its position in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the quarter. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 at the end of the most recent reporting period. Institutional investors own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.